Vector Group Releases Record Tobacco Revenue in 2022

Feb.17.2023
Vector Group Releases Record Tobacco Revenue in 2022
Vector Group reports record tobacco revenue driven by strong sales, achieving historic highs in 2022.

Vector Group has released its annual report for 2022, which highlights a record high in tobacco business revenue bolstered by persistent strong sales.


Vector Group reported a consolidated revenue of $363.8 million in the fourth quarter, marking a 16% increase from the same period last year, or an additional $50.1 million. Revenue from their tobacco business also rose by 18.6%, or $57.2 million, to reach $363.8 million. The wholesale and retail market share for the tobacco sector increased from 4.4% to 5.5% and 4.4% to 5.8%, respectively. Operating revenue stood at $89.3 million, representing an increase of $20.7 million year-over-year. The tobacco sector's operating revenue amounted to $93 million, an 11% increase, or $9.2 million, attributed mainly to the Montego brand's switch to a revenue-based strategy instead of sales volume-based.


Throughout the year, Vector Group's total revenue amounted to $1.44 billion, marking an 18% increase from the previous year, or a $220.3 million increase. Within the company, the tobacco division brought in $1.43 billion in revenue, showing an 18.5% growth from the same period the year before, or a $222.6 million increase. The division's market shares in both wholesale and retail increased from 4.1% and 4.2%, respectively, to 5.4% and 5.5%. As for the reported operating revenue, it totaled $339 million and increased by $18.6 million from the previous year. The tobacco division's operating revenue was $347 million, a 3.7% decrease from the same period the year before, or a $13.3 million decrease, which was mainly due to the investment in the Montego brand that significantly increased its sales and market share.


Howard M. Lorber, President and CEO of Vector Group, stated that by seizing opportunities and significantly increasing market share, the company has created value for shareholders and achieved a historic high in revenue for 2022. The tobacco business saw an 11% increase in revenue in the fourth quarter, reflecting a shift in strategy for the Montego brand from volume-based to profit-based. In 2023, Vector Group will continue to focus on optimizing long-term profits through effective management of sales volume, pricing, and market share.


Vector Group Ltd. is a diversified holding company headquartered in Miami, Florida, with administrative offices in Manhattan and tobacco operations in North Carolina. Through its subsidiaries - Liggett Group LLC and Vector Tobacco Inc. - the company produces and sells high-quality tobacco-related products for adult smokers in the United States.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

New Zealand Vape Company Alt Becomes Government Partner After Suing Over Nicotine Limits
New Zealand Vape Company Alt Becomes Government Partner After Suing Over Nicotine Limits
Health NZ signed a NZD 500,000 contract with New Zealand-owned vape company Alt NZ Limited in December 2025 for its free vape kit programme for smokers, with more than 7,000 kits distributed so far.
Mar.23 by 2FIRSTS.ai
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
The U.S. Food and Drug Administration (FDA) announced on May 5, 2026 that it authorized the marketing of four Glas electronic nicotine delivery system (ENDS) products through the premarket tobacco product application (PMTA) pathway. The authorized products are Classic Menthol, Fresh Menthol, Gold and Sapphire pods, each containing 50mg/ml, or 5%, tobacco-derived nicotine.
May.06 by 2FIRSTS.ai
Seoul to Fine Use of Liquid E-Cigarettes in No-Smoking Areas From April 24
Seoul to Fine Use of Liquid E-Cigarettes in No-Smoking Areas From April 24
Seoul will begin fining the use of all tobacco products, including liquid e-cigarettes, in no-smoking areas from April 24, when the revised Tobacco Business Act takes effect.
Apr.09 by 2FIRSTS.ai
Why Many E-Liquids Today Are "Not Bad, but Not Memorable" – Mylor’s Approach to Experience Design
Why Many E-Liquids Today Are "Not Bad, but Not Memorable" – Mylor’s Approach to Experience Design
From May 8 to 10, 2026, Mylor (Booth E70) will exhibit at The Vaper Expo UK, where it will showcase its systematic experience design solutions for e-liquids. At present, the e-liquid market commonly faces a challenge: many products have “no obvious shortcomings, but lack memorable features.” In response, Mylor has proposed refined solutions across multiple dimensions, including device-adaptive sweetness, progressive cooling sensation, fruit-oriented sourness, and segmented nicotine experience.
May.08
New York’s Lawsuit Against Puff Bar and Other Flavored Vape Companies Survives Key Court Challenge
New York’s Lawsuit Against Puff Bar and Other Flavored Vape Companies Survives Key Court Challenge
According to Law360, a federal judge ruled that makers and distributors of flavored vape brands such as Puff Bar cannot escape New York’s lawsuit seeking to hold them responsible for the youth vaping epidemic. The court found that the state had adequately alleged the companies misrepresented how safe vaping is.
Apr.07 by 2FIRSTS.ai
FDA Adds 18 Tobacco Harmful Constituents and Seeks Comment on 3 More
FDA Adds 18 Tobacco Harmful Constituents and Seeks Comment on 3 More
U.S. Food and Drug Administration published a Federal Register notice finalizing the addition of 18 constituents to the established list of Harmful and Potentially Harmful Constituents in tobacco products. With the update, the list now contains 111 constituents. FDA also proposed adding three more constituents to the list and opened a public comment period ending at 11:59 p.m. ET on May 26, 2026.
Apr.24 by 2FIRSTS.ai